Drug Induced Liver Injury

PHILADELPHIA — In this video, Nancy S. Reau, MD, FAASLD, AGAF, discusses the impact certain herbal and dietary supplements may have on the liver, especially among patients with underlying liver disease.

The FDA granted accelerated approval to Ipsen Pharma’s Iqirvo 80 mg, a first-in-class oral, once-daily peroxisome proliferator-activated receptor agonist for the treatment of primary biliary cholangitis, according to a company release.